Fundies.
English

Segment disclosures

Company overview

Catheter Precision, Inc.

Each reported dimension combination stays separate. Revenue and operating income are shown as reported, with their dates and sources.

Revenue · Reported segment facts

16 dimension combinations 90 retained observations 18 reported periods

Counts describe retained dimensioned rows only. Periods and members can change across reports, and this view does not infer missing values or expected segment totals.

Operating Segments · Product · Cardiac Electrophysiology

Consolidation Items · Product Or Service · Statement Business Segments

Source dimensions srt:ConsolidationItemsAxis=us-gaap:OperatingSegmentsMember;srt:ProductOrServiceAxis=us-gaap:ProductMember;us-gaap:StatementBusinessSegmentsAxis=vtak:CardiacElectrophysiologyMember
PeriodValueUnitFiledEvidence
2026-04-01 – 2026-06-30270000 USD20260814Open filing evidence
2026-01-01 – 2026-06-30518000 USD20260814Open filing evidence
2026-01-01 – 2026-03-31248000 USD20260518Open filing evidence

Operating Segments · Product · Cardiac Electrophysiology · Locke T

Consolidation Items · Product Or Service · Statement Business Segments · Subsegments

Source dimensions srt:ConsolidationItemsAxis=us-gaap:OperatingSegmentsMember;srt:ProductOrServiceAxis=us-gaap:ProductMember;us-gaap:StatementBusinessSegmentsAxis=vtak:CardiacElectrophysiologyMember;us-gaap:SubsegmentsAxis=vtak:LockeTMember
PeriodValueUnitFiledEvidence
2026-04-01 – 2026-06-30216000 USD20260814Open filing evidence
2026-01-01 – 2026-06-30391000 USD20260814Open filing evidence
2026-01-01 – 2026-03-31175000 USD20260518Open filing evidence

Operating Segments · Product · Cardiac Electrophysiology · VIVO

Consolidation Items · Product Or Service · Statement Business Segments · Subsegments

Source dimensions srt:ConsolidationItemsAxis=us-gaap:OperatingSegmentsMember;srt:ProductOrServiceAxis=us-gaap:ProductMember;us-gaap:StatementBusinessSegmentsAxis=vtak:CardiacElectrophysiologyMember;us-gaap:SubsegmentsAxis=vtak:VIVOMember
PeriodValueUnitFiledEvidence
2026-04-01 – 2026-06-3054000 USD20260814Open filing evidence
2026-01-01 – 2026-06-30127000 USD20260814Open filing evidence
2026-01-01 – 2026-03-3173000 USD20260518Open filing evidence

Operating Segments · Product · Private Aviation

Consolidation Items · Product Or Service · Statement Business Segments

Source dimensions srt:ConsolidationItemsAxis=us-gaap:OperatingSegmentsMember;srt:ProductOrServiceAxis=us-gaap:ProductMember;us-gaap:StatementBusinessSegmentsAxis=vtak:PrivateAviationMember
PeriodValueUnitFiledEvidence
2026-04-01 – 2026-06-300 USD20260814Open filing evidence
2026-01-01 – 2026-06-300 USD20260814Open filing evidence
2026-01-01 – 2026-03-310 USD20260518Open filing evidence

Operating Segments · Product · Private Aviation · Locke T

Consolidation Items · Product Or Service · Statement Business Segments · Subsegments

Source dimensions srt:ConsolidationItemsAxis=us-gaap:OperatingSegmentsMember;srt:ProductOrServiceAxis=us-gaap:ProductMember;us-gaap:StatementBusinessSegmentsAxis=vtak:PrivateAviationMember;us-gaap:SubsegmentsAxis=vtak:LockeTMember
PeriodValueUnitFiledEvidence
2026-04-01 – 2026-06-300 USD20260814Open filing evidence
2026-01-01 – 2026-06-300 USD20260814Open filing evidence
2026-01-01 – 2026-03-310 USD20260518Open filing evidence

Operating Segments · Product · Private Aviation · VIVO

Consolidation Items · Product Or Service · Statement Business Segments · Subsegments

Source dimensions srt:ConsolidationItemsAxis=us-gaap:OperatingSegmentsMember;srt:ProductOrServiceAxis=us-gaap:ProductMember;us-gaap:StatementBusinessSegmentsAxis=vtak:PrivateAviationMember;us-gaap:SubsegmentsAxis=vtak:VIVOMember
PeriodValueUnitFiledEvidence
2026-04-01 – 2026-06-300 USD20260814Open filing evidence
2026-01-01 – 2026-06-300 USD20260814Open filing evidence
2026-01-01 – 2026-03-310 USD20260518Open filing evidence

Operating Segments · Service · Cardiac Electrophysiology

Consolidation Items · Product Or Service · Statement Business Segments

Source dimensions srt:ConsolidationItemsAxis=us-gaap:OperatingSegmentsMember;srt:ProductOrServiceAxis=us-gaap:ServiceMember;us-gaap:StatementBusinessSegmentsAxis=vtak:CardiacElectrophysiologyMember
PeriodValueUnitFiledEvidence
2026-04-01 – 2026-06-300 USD20260814Open filing evidence
2026-01-01 – 2026-06-300 USD20260814Open filing evidence
2026-01-01 – 2026-03-310 USD20260518Open filing evidence

Operating Segments · Service · Cardiac Electrophysiology · Hops

Consolidation Items · Product Or Service · Statement Business Segments · Subsegments

Source dimensions srt:ConsolidationItemsAxis=us-gaap:OperatingSegmentsMember;srt:ProductOrServiceAxis=us-gaap:ServiceMember;us-gaap:StatementBusinessSegmentsAxis=vtak:CardiacElectrophysiologyMember;us-gaap:SubsegmentsAxis=vtak:HopsMember
PeriodValueUnitFiledEvidence
2026-04-01 – 2026-06-300 USD20260814Open filing evidence
2026-01-01 – 2026-06-300 USD20260814Open filing evidence
2026-01-01 – 2026-03-310 USD20260518Open filing evidence

Operating Segments · Service · Cardiac Electrophysiology · Luxe

Consolidation Items · Product Or Service · Statement Business Segments · Subsegments

Source dimensions srt:ConsolidationItemsAxis=us-gaap:OperatingSegmentsMember;srt:ProductOrServiceAxis=us-gaap:ServiceMember;us-gaap:StatementBusinessSegmentsAxis=vtak:CardiacElectrophysiologyMember;us-gaap:SubsegmentsAxis=vtak:LuxeMember
PeriodValueUnitFiledEvidence
2026-04-01 – 2026-06-300 USD20260814Open filing evidence
2026-01-01 – 2026-06-300 USD20260814Open filing evidence
2026-01-01 – 2026-03-310 USD20260518Open filing evidence

Operating Segments · Service · Private Aviation

Consolidation Items · Product Or Service · Statement Business Segments

Source dimensions srt:ConsolidationItemsAxis=us-gaap:OperatingSegmentsMember;srt:ProductOrServiceAxis=us-gaap:ServiceMember;us-gaap:StatementBusinessSegmentsAxis=vtak:PrivateAviationMember
PeriodValueUnitFiledEvidence
2026-04-01 – 2026-06-30749000 USD20260814Open filing evidence
2026-01-01 – 2026-06-30933000 USD20260814Open filing evidence
2026-01-01 – 2026-03-31184000 USD20260518Open filing evidence

Operating Segments · Service · Private Aviation · Hops

Consolidation Items · Product Or Service · Statement Business Segments · Subsegments

Source dimensions srt:ConsolidationItemsAxis=us-gaap:OperatingSegmentsMember;srt:ProductOrServiceAxis=us-gaap:ServiceMember;us-gaap:StatementBusinessSegmentsAxis=vtak:PrivateAviationMember;us-gaap:SubsegmentsAxis=vtak:HopsMember
PeriodValueUnitFiledEvidence
2026-04-01 – 2026-06-30722000 USD20260814Open filing evidence
2026-01-01 – 2026-06-30864000 USD20260814Open filing evidence
2026-01-01 – 2026-03-31142000 USD20260518Open filing evidence

Operating Segments · Service · Private Aviation · Luxe

Consolidation Items · Product Or Service · Statement Business Segments · Subsegments

Source dimensions srt:ConsolidationItemsAxis=us-gaap:OperatingSegmentsMember;srt:ProductOrServiceAxis=us-gaap:ServiceMember;us-gaap:StatementBusinessSegmentsAxis=vtak:PrivateAviationMember;us-gaap:SubsegmentsAxis=vtak:LuxeMember
PeriodValueUnitFiledEvidence
2026-04-01 – 2026-06-3027000 USD20260814Open filing evidence
2026-01-01 – 2026-06-3069000 USD20260814Open filing evidence
2026-01-01 – 2026-03-3142000 USD20260518Open filing evidence

Operating Segments · Cardiac Electrophysiology

Consolidation Items · Statement Business Segments

Source dimensions srt:ConsolidationItemsAxis=us-gaap:OperatingSegmentsMember;us-gaap:StatementBusinessSegmentsAxis=vtak:CardiacElectrophysiologyMember
PeriodValueUnitFiledEvidence
2026-04-01 – 2026-06-30270000 USD20260814Open filing evidence
2026-01-01 – 2026-06-30518000 USD20260814Open filing evidence
2026-01-01 – 2026-03-31248000 USD20260518Open filing evidence

Operating Segments · Private Aviation

Consolidation Items · Statement Business Segments

Source dimensions srt:ConsolidationItemsAxis=us-gaap:OperatingSegmentsMember;us-gaap:StatementBusinessSegmentsAxis=vtak:PrivateAviationMember
PeriodValueUnitFiledEvidence
2026-04-01 – 2026-06-30749000 USD20260814Open filing evidence
2026-01-01 – 2026-06-30933000 USD20260814Open filing evidence
2026-01-01 – 2026-03-31184000 USD20260518Open filing evidence

Dermatology

Statement Business Segments

Source dimensions us-gaap:StatementBusinessSegmentsAxis=rmed:DermatologyMember
PeriodValueUnitFiledEvidence
2021-04-01 – 2021-06-30996000 USD20210811Open filing evidence
2021-01-01 – 2021-06-302110000 USD20210811Open filing evidence
2021-01-01 – 2021-03-311114000 USD20210512Open filing evidence
2020-01-01 – 2020-12-314146000 USD20210317Open filing evidence
2020-07-01 – 2020-09-30846000 USD20201116Open filing evidence
2020-01-01 – 2020-09-302929000 USD20201116Open filing evidence
2020-04-01 – 2020-06-30822000 USD20210811Open filing evidence
2020-01-01 – 2020-06-302083000 USD20210811Open filing evidence
2020-01-01 – 2020-03-311261000 USD20210512Open filing evidence
2019-01-01 – 2019-12-315924000 USD20210317Open filing evidence
2019-07-01 – 2019-09-301682000 USD20201116Open filing evidence
2019-01-01 – 2019-09-304688000 USD20201116Open filing evidence
2019-04-01 – 2019-06-301719000 USD20200811Open filing evidence
2019-01-01 – 2019-06-303006000 USD20200811Open filing evidence
2019-01-01 – 2019-03-311287000 USD20200514Open filing evidence
2018-01-01 – 2018-12-314705000 USD20200311Open filing evidence
2018-07-01 – 2018-09-301275000 USD20191129Open filing evidence
2018-01-01 – 2018-09-303296000 USD20191129Open filing evidence
2018-04-01 – 2018-06-301142000 USD20191129Open filing evidence
2018-01-01 – 2018-06-302021000 USD20191129Open filing evidence
2018-01-01 – 2018-03-31879000 USD20190514Open filing evidence
2017-01-01 – 2017-12-315611000 USD20190315Open filing evidence
2017-07-01 – 2017-09-301248000 USD20181114Open filing evidence
2017-01-01 – 2017-09-303865000 USD20181114Open filing evidence

Vascular

Statement Business Segments

Source dimensions us-gaap:StatementBusinessSegmentsAxis=rmed:VascularMember
PeriodValueUnitFiledEvidence
2021-04-01 – 2021-06-309000 USD20210811Open filing evidence
2021-01-01 – 2021-06-3013000 USD20210811Open filing evidence
2021-01-01 – 2021-03-314000 USD20210512Open filing evidence
2020-01-01 – 2020-12-31259000 USD20210317Open filing evidence
2020-07-01 – 2020-09-3068000 USD20201116Open filing evidence
2020-01-01 – 2020-09-30259000 USD20201116Open filing evidence
2020-04-01 – 2020-06-3078000 USD20210811Open filing evidence
2020-01-01 – 2020-06-30191000 USD20210811Open filing evidence
2020-01-01 – 2020-03-31113000 USD20210512Open filing evidence
2019-01-01 – 2019-12-311275000 USD20210317Open filing evidence
2019-07-01 – 2019-09-30226000 USD20201116Open filing evidence
2019-01-01 – 2019-09-301121000 USD20201116Open filing evidence
2019-04-01 – 2019-06-30434000 USD20200811Open filing evidence
2019-01-01 – 2019-06-30895000 USD20200811Open filing evidence
2019-01-01 – 2019-03-31461000 USD20200514Open filing evidence
2018-01-01 – 2018-12-311552000 USD20200311Open filing evidence
2018-07-01 – 2018-09-30789000 USD20191129Open filing evidence
2018-01-01 – 2018-09-30973000 USD20191129Open filing evidence
2018-04-01 – 2018-06-3094000 USD20191129Open filing evidence
2018-01-01 – 2018-06-30184000 USD20191129Open filing evidence
2018-01-01 – 2018-03-3190000 USD20190514Open filing evidence
2017-01-01 – 2017-12-31259000 USD20190315Open filing evidence
2017-07-01 – 2017-09-3043000 USD20181114Open filing evidence
2017-01-01 – 2017-09-3068000 USD20181114Open filing evidence